Suzhou Suncadia Biopharmaceuticals Co., Ltd.: clinical-trial pipeline
Suzhou Suncadia Biopharmaceuticals Co., Ltd. is the sponsor of 102 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 72 are not yet finished and 2 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Phase 1 | 28 |
| Phase 3 | 25 |
| Phase 2 | 22 |
| Phase 1/2 | 20 |
| Phase 2/3 | 6 |
| Phase 4 | 1 |
Trials by status
| Status | Trials |
|---|---|
| Recruiting | 51 |
| Unknown | 16 |
| Active, not recruiting | 11 |
| Not yet recruiting | 10 |
| Completed | 8 |
| Terminated | 5 |
| Withdrawn or not authorised | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 90 |
| Gastroenterology and liver | 10 |
| Immunology and rheumatology | 8 |
| Women's health and obstetrics | 7 |
| Dermatology | 6 |
| Nephrology and urology | 6 |
| Musculoskeletal | 5 |
Countries
| Country | Trials |
|---|---|
| China | 93 |
| Australia | 1 |
| Japan | 1 |
| South Korea | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-07 | New trial posted | An Open, Multicenter Phase II Clinical Trial of SHR-A2009 Combined With Other Anti-tumor… |
| 2026-09-21 | New trial posted | A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT06703177 | A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With Solid Tumors | Phase 1/2 | Recruiting | China |
| NCT06671379 | A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC | Phase 3 | Active, not recruiting | China |
| NCT06618664 | A Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab Versus Sintilimab Combined With Bevaci… | Phase 3 | Recruiting | China |
| NCT07676162 | A Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as Fir… | Phase 3 | Recruiting | China |
| NCT07123129 | A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors | Phase 1 | Recruiting | China |
| NCT04950322 | A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal Cancer | Phase 3 | Active, not recruiting | China |
| NCT07239596 | Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carc… | Phase 1/2 | Recruiting | China |
| NCT06754930 | A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC | Phase 1/2 | Recruiting | China |
| NCT07028281 | A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors | Phase 2 | Recruiting | China |
| NCT07478302 | A Study of SHR-2524 Plus Bevacizumab in the First-line Treatment of Advanced Hepatocellular Carcinoma | Phase 1 | Recruiting | China |
| NCT07298772 | A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors | Phase 1/2 | Recruiting | China |
| NCT06907628 | A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors | Phase 1 | Recruiting | China |
| NCT06643754 | A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors | Phase 1/2 | Recruiting | China |
| NCT06778031 | A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract… | Phase 2 | Recruiting | China |
| NCT06929624 | A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma | Phase 3 | Active, not recruiting | China |
| NCT07751341 | A Clinical Study of SHR-9839 as Monotherapy or in Combination With Chemotherapy Plus Adebrelimab Versus Chemo… | Phase 2 | Recruiting | China |
| NCT07028268 | A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors | Phase 2 | Recruiting | China |
| NCT07676903 | A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors | Phase 1 | Recruiting | Australia, China |
| NCT06484777 | A Clinical Study of SHR-9539 in Patients With Multiple Myeloma | Phase 1 | Recruiting | China |
| NCT07830199 | A Clinical Study of SHR-4595 Injection in Patients With Advanced Solid Tumors to Evaluate Safety, Tolerabilit… | Phase 1 | Not yet recruiting | China |
| NCT06840002 | A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer | Phase 1/2 | Recruiting | China |
| NCT07111832 | A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer | Phase 3 | Recruiting | China |
| NCT05671822 | Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2 Expression Gastric Cancer | Phase 2 | Recruiting | China |
| NCT06737731 | A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors | Phase 1/2 | Recruiting | China |
| NCT07679360 | A Study of Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in S… | Phase 3 | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Suzhou Suncadia Biopharmaceuticals Co., Ltd. clinical trials: 72 open, 31 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/suzhou-suncadia-biopharmaceuticals-co-ltd/, data as of 2026-10-25.